Accelerating the Development of Biomarkers for Drug Safety:

Workshop Summary

Status: Available Now

Size: 100 pages, 6 x 9

Publication Year:2009

Print	List Price


PAPERBACK ISBN-10: 0-309-13124-3 ISBN-13: 978-0-309-13124-7	$21.00	Add to Cart

PDF			About PDF

Authors:
Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine
Authoring Organizations

Description:

Paste into your Web page:

<!-- Start NAP Book Display -->
<object classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=8,0,0,0" width="175" height="250" id="napbookwrapper" align="middle">
<param name="allowScriptAccess" value="always" />
<param name="movie" value="http://www.nap.edu/napbookwrapper.swf" />
<param name="quality" value="high" />
<param name="wmode" value="transparent" />
<param name="flashvars" value="wid=5422652920130523180334&record_id=12587" />
<embed src="http://www.nap.edu/napbookwrapper.swf" quality="high" flashvars="wid=5422652920130523180334&record_id=12587" wmode="transparent" bgcolor="#ffffff" width="175" height="250" name="napbookwrapper" align="middle" allowScriptAccess="always" allowFullScreen="false" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"></embed>
</object>

Preview

Free Resources

Full Text
Jump to this book's table of contents to begin reading online for free.

Related Items:
Related Titles

PDF Summary
Download the summary in PDF.

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter	i-xvi
1 Introduction	1-5	(skim)
2 Overview of Key Issues	6-16	(skim)
3 Cardiac Safety Biomarkers	17-28	(skim)
4 Assessing and Predicting Kidney Safety	29-41	(skim)
5 Biomarkers of Acute Idiosyncratic Hepatocellular Injury in Clinical Trials	42-57	(skim)
6 Future Considerations	58-64	(skim)
Appendix A: Workshop Agenda	65-70	(skim)
Appendix B: Speaker Biographies	71-84	(skim)

Description

Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development.

On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.

Accelerating the Development of Biomarkers for Drug Safety:

Workshop Summary

Citation Manager

Description

Authoring Organizations

Search This Book

SIGN UP FOR...